The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity
Tóm tắt
Từ khóa
Tài liệu tham khảo
Wieckowska, 2005, Nonalcoholic fatty liver disease in the pediatric population: a review, Curr Opin Pediatr, 17, 636, 10.1097/01.mop.0000172816.79637.c5
Brunt, 2004, Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens, Hum Pathol, 35, 1070, 10.1016/j.humpath.2004.04.017
Adams, 2005, The natural history of nonalcoholic fatty liver disease: a population-based cohort study, Gastroenterology, 129, 113, 10.1053/j.gastro.2005.04.014
Matteoni, 1999, Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity, Gastroenterology, 116, 1413, 10.1016/S0016-5085(99)70506-8
Diehl, 2002, Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines, Am J Physiol Gastrointest Liver Physiol, 282, G1, 10.1152/ajpgi.00384.2001
McCullough, 2004, The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease, Clin Liver Dis, 8, 521, 10.1016/j.cld.2004.04.004
Listenberger, 2003, Triglyceride accumulation protects against fatty acid-induced lipotoxicity, Proc Natl Acad Sci U S A, 100, 3077, 10.1073/pnas.0630588100
Yamaguchi, 2007, Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis, HEPATOLOGY, 45, 1366, 10.1002/hep.21655
Ginsberg, 2006, Is the slippery slope from steatosis to steatohepatitis paved with triglyceride or cholesterol?, Cell Metab, 4, 179, 10.1016/j.cmet.2006.08.010
Unger, 2003, Lipid overload and overflow: metabolic trauma and the metabolic syndrome, Trends Endocrinol Metab, 14, 398, 10.1016/j.tem.2003.09.008
Bouchier-Hayes, 2005, Mitochondria: pharmacological manipulation of cell death, J Clin Invest, 115, 2640, 10.1172/JCI26274
Caldwell, 2004, Mitochondria in nonalcoholic fatty liver disease, Clin Liver Dis, 8, 595, 10.1016/j.cld.2004.04.009
Fromenty, 2004, The ins and outs of mitochondrial dysfunction in NASH, Diabetes Metab, 30, 121, 10.1016/S1262-3636(07)70098-8
Ricci, 2003, Mitochondrial functions during cell death, a complex (I-V) dilemma, Cell Death Differ, 10, 488, 10.1038/sj.cdd.4401225
Feldstein, 2006, Bax inhibition protects against free fatty acid-induced lysosomal permeabilization, Am J Physiol Gastrointest Liver Physiol, 290, G1339, 10.1152/ajpgi.00509.2005
Canbay, 2003, Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression, HEPATOLOGY, 38, 1188, 10.1053/jhep.2003.50472
Feldstein, 2003, Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice, J Hepatol, 39, 978, 10.1016/S0168-8278(03)00460-4
Feldstein, 2004, Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway, HEPATOLOGY, 40, 185, 10.1002/hep.20283
Feldstein, 2003, Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis, Gastroenterology, 125, 437, 10.1016/S0016-5085(03)00907-7
Browning, 2004, Molecular mediators of hepatic steatosis and liver injury, J Clin Invest, 114, 147, 10.1172/JCI200422422
Pessayre, 2004, Mitochondrial injury in steatohepatitis, Eur J Gastroenterol Hepatol, 16, 1095, 10.1097/00042737-200411000-00003
Day, 1998, Steatohepatitis: a tale of two “hits”?, Gastroenterology, 114, 842, 10.1016/S0016-5085(98)70599-2
Mari, 2006, Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis, Cell Metab, 4, 185, 10.1016/j.cmet.2006.07.006
Schaffer, 2003, Lipotoxicity: when tissues overeat, Curr Opin Lipidol, 14, 281, 10.1097/00041433-200306000-00008
Shimabukuro, 1998, Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes, Proc Natl Acad Sci U S A, 95, 2498, 10.1073/pnas.95.5.2498